美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Infinity Natural Resources

16.33

+0.42002.64%

盘前：16.340.0100+0.06%08:00 EDT

成交量：14.86万

成交额：242.46万

市值：2.49亿

市盈率：- -

高：16.64

开：16.02

低：15.72

收：15.91

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

Keybanc：维持Infinity Natural评级，由增持调整至增持评级, 目标价由26.00美元调整至24.00美元。

云南白药：云核医药的INR102注射液获得药物临床试验批准

格隆汇资讯

花旗：维持Infinity Natural(INR.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至23.00美元。

Infinity Natural Resources, Inc.2024财年实现净利润49.29百万美元，同比减少43.13%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/INR"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INR\",,,,,undefined,":{"symbol":"INR","market":"US","secType":"STK","nameCN":"Infinity Natural Resources","latestPrice":16.33,"timestamp":1746561600000,"preClose":15.91,"halted":0,"volume":148582,"hourTrading":{"tag":"盘前","latestPrice":16.34,"preClose":16.33,"latestTime":"08:00 EDT","volume":223,"amount":3624.0702280000005,"timestamp":1746619200719},"delay":0,"floatShares":14383639,"shares":15237500,"eps":0,"marketStatus":"盘前交易","change":0.42,"latestTime":"05-07 08:31:49 EDT","open":16.02,"high":16.635,"low":15.72,"amount":2424640.5609,"amplitude":0.057511,"askPrice":18.79,"askSize":100,"bidPrice":14.94,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746624600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1738299600000,"exchange":"NYSE","adjPreClose":16.33,"aum":0,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":16.34,"preClose":16.33,"latestTime":"08:00 EDT","volume":223,"amount":3624.0702280000005,"timestamp":1746619200719},"postHourTrading":{"tag":"盘后","latestPrice":16.33,"preClose":16.33,"latestTime":"16:05 EDT","volume":1131,"amount":18469.23,"timestamp":1746561911468},"volumeRatio":0.8307093308913129},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INR\",,,,,undefined,":{"symbol":"INR","floatShares":14383639,"roa":"5.59%","roe":"10.20%","lyrEps":0,"volumeRatio":0.8307093308913129,"shares":15237500,"dividePrice":0,"high":16.635,"amplitude":0.057511,"preClose":15.91,"low":15.72,"week52Low":13.64,"pbRate":"0.49","psRate":"0.96","week52High":23,"institutionHeld":0,"latestPrice":16.33,"eps":0,"divideRate":0,"volume":148582,"delay":0,"ttmEps":0,"open":16.02,"prevYearClose":20,"prevWeekClose":16.24,"prevMonthClose":15.35,"prevQuarterClose":18.75,"fiveDayClose":16.03,"twentyDayClose":14.91,"sixtyDayClose":21.3},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/INR\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INR\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529386622","title":"Keybanc：维持Infinity Natural评级，由增持调整至增持评级, 目标价由26.00美元调整至24.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529386622","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529386622?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:52","pubTimestamp":1745247176,"startTime":"0","endTime":"0","summary":"Keybanc：维持Infinity Natural(INR.US)评级，由增持调整至增持评级, 目标价由26.00美元调整至24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421225554973f85a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421225554973f85a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INR"],"gpt_icon":0},{"id":"2525101866","title":"云南白药：云核医药的INR102注射液获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2525101866","media":"格隆汇资讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525101866?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 17:39","pubTimestamp":1744105164,"startTime":"0","endTime":"0","summary":"格隆汇4月8日丨云南白药公布，公司全资子公司云核医药(天津)有限公司于近日收到国家药品监督管理局下发的《药物临床试验批准通知书》，经审查，云核医药的INR102注射液临床试验申请符合药品注册的有关要求，同意本品开展前列腺癌的临床试验。本品为云核医药研发的化学1类放射性治疗类创新药，拟用于治疗已经接受过雄激素受体通路抑制剂和紫杉烷类药物化疗的前列腺特异性膜抗原阳性的转移性去势抵抗性前列腺癌成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040817400494cf5e57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040817400494cf5e57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INR","BK4213"],"gpt_icon":0},{"id":"2524786010","title":"花旗：维持Infinity Natural(INR.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至23.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2524786010","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524786010?lang=zh_cn&edition=fundamental","pubTime":"2025-04-04 22:43","pubTimestamp":1743777814,"startTime":"0","endTime":"0","summary":"花旗：维持Infinity Natural(INR.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至23.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/04224349310106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INR"],"gpt_icon":0},{"id":"2523690699","title":"Infinity Natural Resources, Inc.2024财年实现净利润49.29百万美元，同比减少43.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523690699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523690699?lang=zh_cn&edition=fundamental","pubTime":"2025-03-29 23:00","pubTimestamp":1743260446,"startTime":"0","endTime":"0","summary":"3月29日，Infinity Natural Resources, Inc.公布财报，公告显示公司2024财年净利润为49.29百万美元，同比减少43.13%；其中营业收入为2.59亿美元，同比增加59.88%，每股基本收益为0.84美元。机构评级：截至2025年3月29日，当前有8家机构对Infinity Natural Resources, Inc.目标价做出预测，其中目标均价为27.62美元，其中最低目标价为23.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250329230054a4468092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250329230054a4468092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INR"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-28","symbol":"INR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1745985600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INR","date":"2025-05-06","current":4.918813,"percent":0.8,"low":2.025379,"twenty":2.266867,"median":2.453469,"eighty":4.918813,"high":10.238786,"avg":3.528661,"sd":1.583089,"marketCap":242428625},"quantilePoints":[{"date":"2025-01-31","current":10.238786,"twenty":10.238786,"median":10.238786,"eighty":10.238786,"marketCap":1177777780},{"date":"2025-02-07","current":2.383205,"twenty":2.426976,"median":2.479962,"eighty":2.521429,"marketCap":274142500},{"date":"2025-02-14","current":2.332523,"twenty":2.418913,"median":2.453469,"eighty":2.505303,"marketCap":268312500},{"date":"2025-02-21","current":2.354409,"twenty":2.374682,"median":2.426976,"eighty":2.487795,"marketCap":270830000},{"date":"2025-02-28","current":2.08948,"twenty":2.254197,"median":2.383781,"eighty":2.477888,"marketCap":240355000},{"date":"2025-03-07","current":2.025379,"twenty":2.198216,"median":2.354409,"eighty":2.458076,"marketCap":232981375},{"date":"2025-03-14","current":2.222751,"twenty":2.168821,"median":2.318701,"eighty":2.453469,"marketCap":255685250},{"date":"2025-03-21","current":2.33667,"twenty":2.175836,"median":2.31945,"eighty":2.432275,"marketCap":268789500},{"date":"2025-03-28","current":5.598976,"twenty":2.181814,"median":2.333099,"eighty":2.432275,"marketCap":275951125},{"date":"2025-04-04","current":5.348552,"twenty":2.19043,"median":2.354409,"eighty":2.487795,"marketCap":263608750},{"date":"2025-04-11","current":4.788964,"twenty":2.201269,"median":2.374106,"eighty":4.62016,"marketCap":236028875},{"date":"2025-04-17","current":4.853889,"twenty":2.215057,"median":2.383781,"eighty":4.785254,"marketCap":239228750},{"date":"2025-04-25","current":4.714764,"twenty":2.229904,"median":2.405552,"eighty":4.788964,"marketCap":232371875},{"date":"2025-05-02","current":4.866255,"twenty":2.253989,"median":2.440222,"eighty":4.882332,"marketCap":239838250},{"date":"2025-05-06","current":4.918813,"twenty":2.266867,"median":2.453469,"eighty":4.918813,"marketCap":242428625}],"updateTime":1746621109300}}}